Shelf life is determined by the manufacturer and is commonly up to 2 years, depending on formulation and packaging
Mendias stresses that when it comes to unapproved peptides, there's still a lot where we don't understand the safety profile. Whats Behind the Proposed Change OVER THE YEARS , the gray market for experimental peptides has ballooned, driven initially by bodybuilders looking for a competitive edge and then later by biohackers and people with unmet medical needs
Common side effects may include mild irritation at the injection site, water retention, or headaches
Strong evidence supporting use for corneal injuries and neurotrophic keratopathy once approved
Starting at 250 mcg reduces the risk
The Human Evidence Problem Here's the honest gap: there are essentially no completed, published, peer-reviewed randomized controlled trials of BPC-157 in humans for any indication